| Patent | Date |
|---|
Alpha-2-adrenergic Receptor Agonists For Improving Vision
App 20220288031 - Dibas; Mohammed ; et al. | 2022-09-15 |
Pharmaceutical Compositions Comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3h-imidazole Derivatives For Treating Retinal Diseases
App 20220233505 - Dibas; Mohammed I. ; et al. | 2022-07-28 |
Use Of Alpha-2-adrenergic Receptor Agonists For Improving Vision
App 20220160623 - Dibas; Mohammed ; et al. | 2022-05-26 |
Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3H-imidazole derivatives for treating retinal diseases
Grant 11,331,306 - Dibas , et al. May 17, 2 | 2022-05-17 |
Heavy Chain Only Antibodies To Pdgf
App 20220098295 - Liang; Yanbin ; et al. | 2022-03-31 |
Pharmaceutical Compositions Comprising (3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl)methanol
App 20220008393 - Dibas; Mohammed I. ; et al. | 2022-01-13 |
Heavy Chain Only Antibodies To Ang-2
App 20210324064 - Liang; Yanbin ; et al. | 2021-10-21 |
Alpha-2-adrenergic receptor agonists for treatment of presbyopia, visual glare, visual starbursts, visual halos and night myopia
Grant 11,077,053 - Dibas , et al. August 3, 2 | 2021-08-03 |
The Use Of Alpha-2-adrenergic Receptor Agonists For Improving Vision
App 20210205273 - Dibas; Mohammed ; et al. | 2021-07-08 |
Heavy chain only antibodies to ANG-2
Grant 11,046,756 - Liang , et al. June 29, 2 | 2021-06-29 |
Heavy chain only antibodies to PDGF
Grant 11,028,163 - Liang , et al. June 8, 2 | 2021-06-08 |
Use Of Alpha-2-adrenergic Receptor Agonists For Improving Vision
App 20210059930 - Dibas; Mohammed ; et al. | 2021-03-04 |
Pharmaceutical Compositions Comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3h-imidazole Derivatives For Treating Retinal Diseases
App 20200390747 - Dibas; Mohammed I. ; et al. | 2020-12-17 |
Methods Of Treating Alpha Adrenergic Mediated Conditions
App 20200330428 - Gil; Daniel W. ; et al. | 2020-10-22 |
Pharmaceutical Compositions Comprising (3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl)methanol
App 20200206193 - Dibas; Mohammed I. ; et al. | 2020-07-02 |
Heavy Chain Only Antibodies To Pdgf
App 20200123240 - Liang; Yanbin ; et al. | 2020-04-23 |
Alpha Adrenergic Agonists For The Treatment Of Tissue Trauma
App 20200054608 - Gil; Daniel W. ; et al. | 2020-02-20 |
Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3H-imidazole derivatives for treating retinal diseases
Grant 10,555,933 - Dibas , et al. Feb | 2020-02-11 |
Heavy Chain Only Antibodies To Ang-2
App 20190248882 - Liang; Yanbin ; et al. | 2019-08-15 |
Pharmaceutical Compositions Comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3h-imidazole Derivatives For Treating Retinal Diseases
App 20190240200 - Dibas; Mohammed I. ; et al. | 2019-08-08 |
Heavy chain only antibodies to PDGF
Grant 10,308,711 - Liang , et al. | 2019-06-04 |
Heavy chain only antibodies to ANG-2
Grant 10,266,589 - Liang , et al. | 2019-04-23 |
Method of activating regulatory T cells with alpha-2B adrenergic receptor agonists
Grant 10,251,865 - Gil , et al. | 2019-04-09 |
Pharmaceutical compositions comprising 7-(1H-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for treating skin diseases and conditions
Grant 10,201,535 - Dibas , et al. Feb | 2019-02-12 |
Methods Of Treating Alpha Adrenergic Mediated Conditions
App 20180344692 - Gil; Daniel W. ; et al. | 2018-12-06 |
Methods Of Treating Alpha Adrenergic Mediated Conditions
App 20180071260 - Gil; Daniel W. ; et al. | 2018-03-15 |
Method Of Activating Regulatory T Cells With Alpha-2b Adrenergic Receptor Agonists
App 20180071259 - Gil; Daniel W. ; et al. | 2018-03-15 |
Alpha-2 adrenergic agonist having long duration of intraocular pressure-lowering effect
Grant 9,889,088 - Dibas , et al. February 13, 2 | 2018-02-13 |
Methods of treating .alpha. adrenergic mediated conditions
Grant 9,849,113 - Gil , et al. December 26, 2 | 2017-12-26 |
Pharmaceutical Compositions Comprising 7-(1h-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline For Treating Skin Diseases And Conditions
App 20170182028 - Dibas; Mohammed I. ; et al. | 2017-06-29 |
Pharmaceutical Compositions Comprising (3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl)methanol
App 20170172983 - Dibas; Mohammed I. ; et al. | 2017-06-22 |
Methods Of Treating Alpha Adrenergic Mediated Conditions
App 20170172982 - Gil; Daniel W. ; et al. | 2017-06-22 |
Treatment of inflammatory bowel disease
Grant 9,637,467 - Donde , et al. May 2, 2 | 2017-05-02 |
Heavy Chain Only Antibodies To Ang-2
App 20170107279 - Liang; Yanbin ; et al. | 2017-04-20 |
Methods of treating .alpha. adrenergic mediated conditions
Grant 9,623,006 - Gil , et al. April 18, 2 | 2017-04-18 |
Pharmaceutical Compositions Comprising 7-(1h-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline For Treating Skin Diseases And Conditions
App 20170095466 - Dibas; Mohammed I. ; et al. | 2017-04-06 |
Method Of Activating Regulatory T Cells With Alpha-2b Adrenergic Receptor Agonists
App 20170079956 - Gil; Daniel W. ; et al. | 2017-03-23 |
Heavy Chain Only Antibodies To Pdgf
App 20170044247 - Liang; Yanbin ; et al. | 2017-02-16 |
Methods for treating diseases of the retina
Grant 9,561,234 - Kusari , et al. February 7, 2 | 2017-02-07 |
Pharmaceutical compositions comprising (3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl)methanol
Grant 9,555,021 - Gil January 31, 2 | 2017-01-31 |
Method of activating regulatory T cells with alpha-2B adrenergic receptor agonists
Grant 9,545,394 - Gil , et al. January 17, 2 | 2017-01-17 |
Alpha adrenergic receptor modulators
Grant 9,522,150 - Chow , et al. December 20, 2 | 2016-12-20 |
Ester Pro-drugs Of [3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl] Methanol For Treating Skin Diseases And Conditions
App 20160354346 - Dibas; Mohammed I. ; et al. | 2016-12-08 |
Pharmaceutical Compositions Comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3himidazole Derivatives For Treating Retinal Diseases
App 20160303083 - Dibas; Mohammed I. ; et al. | 2016-10-20 |
Method Of Activating Regulatory T Cells With Alpha-2b Adrenergic Receptor Agonists
App 20160158199 - Gil; Daniel W. ; et al. | 2016-06-09 |
Pharmaceutical Compositions Comprising 7-(1h-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline For Treating Skin Diseases And Conditions
App 20160151349 - Dibas; Mohammed I. ; et al. | 2016-06-02 |
Pharmaceutical compositions comprising 7-(1 H-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for treating skin diseases and conditions
Grant 9,308,201 - Dibas , et al. April 12, 2 | 2016-04-12 |
Treatment Of Inflammatory Bowel Disease
App 20160096817 - Donde; Yariv ; et al. | 2016-04-07 |
Method of activating regulatory T cells with alpha-2B adrenergic receptor agonists
Grant 9,289,420 - Gil , et al. March 22, 2 | 2016-03-22 |
Pharmaceutical compositions comprising 7-(1 H-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for treating skin diseases and conditions
Grant 9,283,217 - Dibas , et al. March 15, 2 | 2016-03-15 |
Pharmaceutical Compositions Comprising (3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl)methanol
App 20160067222 - Dibas; Mohammed I. ; et al. | 2016-03-10 |
Pharmaceutical Compositions Comprising 7-(1h-imidazol-4-ylmethyl)-5,6,7,8- Tetrahydro-quinoline For Treating Skin Diseases And Conditions
App 20160051534 - Dibas; Mohammed I. ; et al. | 2016-02-25 |
Pharmaceutical Compositions Comprising (3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl)methanol
App 20160038466 - Gil; Daniel W. | 2016-02-11 |
Muscarinic Agonists
App 20160039819 - BURSTEIN; Ethan S. ; et al. | 2016-02-11 |
Pharmaceutical compositions comprising (3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl)methanol
Grant 9,193,690 - Gil November 24, 2 | 2015-11-24 |
Methods For Treating Diseases Of The Retina
App 20150290215 - Kusari; Jyotirmoy ; et al. | 2015-10-15 |
Treatment of inflammatory bowel disease
Grant 9,156,810 - Donde , et al. October 13, 2 | 2015-10-13 |
Pharmaceutical Compositions Comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3himidazole Derivatives For Treating Retinal Diseases
App 20150250764 - Dibas; Mohammed I. ; et al. | 2015-09-10 |
Pharmaceutical Compositions Comprising 7-(1h-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline For Treating Skin Diseases And Conditions
App 20150231128 - Dibas; Mohammed I. ; et al. | 2015-08-20 |
Methods Of Treating Alpha Adrenergic Mediated Conditions
App 20150224080 - Gil; Daniel W. ; et al. | 2015-08-13 |
Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3H-imidazole derivatives for treating retinal diseases
Grant 9,095,576 - Dibas , et al. August 4, 2 | 2015-08-04 |
Alpha Adrenergic Receptor Modulators
App 20150209351 - Chow; Ken ; et al. | 2015-07-30 |
Ester Pro-drugs Of [3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl] Methanol For Treating Skin Diseases And Conditions
App 20150148394 - Dibas; Mohammed I. ; et al. | 2015-05-28 |
Alpha adrenergic receptor modulators
Grant 9,040,532 - Chow , et al. May 26, 2 | 2015-05-26 |
Methods of treating alpha adrenergic mediated conditions
Grant 9,034,910 - Gil , et al. May 19, 2 | 2015-05-19 |
Methods for treating diseases of the retina
Grant 9,018,202 - Kusari , et al. April 28, 2 | 2015-04-28 |
Pharmaceutical Compositions Comprising (3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl)methanol
App 20150080445 - Gil; Daniel W. | 2015-03-19 |
Treatment Of Inflammatory Bowel Disease
App 20150018400 - DONDE; YARIV ; et al. | 2015-01-15 |
Alpha Adrenergic Agonists For The Treatment Of Tissue Trauma
App 20140329874 - Gil; Daniel W. ; et al. | 2014-11-06 |
Ester pro-drugs of [3-(1-(1H-imidazol-4-YL)ethyl)-2-methylphenyl] methanol for treating retinal diseases
Grant 8,853,251 - Dibas , et al. October 7, 2 | 2014-10-07 |
Alpha-2 Adrenergic Agonist For Treating Intraocular Pressure And Ocular Diseases Through Intravitreal And Intracameral Routes
App 20140275197 - DIBAS; Mohammed I. ; et al. | 2014-09-18 |
Therapeutic compounds
Grant 8,815,923 - Sinha , et al. August 26, 2 | 2014-08-26 |
Geminal dialkyl prostanoids
Grant 8,754,122 - Donde , et al. June 17, 2 | 2014-06-17 |
Method Of Activating Regulatory T Cells With Alpha-2b Adrenergic Receptor Agonists
App 20140066483 - Gil; Daniel W. ; et al. | 2014-03-06 |
Ester Pro-drugs Of [3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl] Methanol For Treating Retinal Diseases
App 20140057958 - DIBAS; Mohammed I. ; et al. | 2014-02-27 |
Ester pro-drugs of [3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl] methanol for treating retinal diseases
Grant 8,653,123 - Dibas , et al. February 18, 2 | 2014-02-18 |
Ester Pro-drugs Of [3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl] Methanol For Treating Skin Diseases And Conditions
App 20130296394 - Dibas; Mohammed I. ; et al. | 2013-11-07 |
Method of activating regulatory T cells with alpha-2B adrenergic receptor agonists
Grant 8,575,207 - Gil , et al. November 5, 2 | 2013-11-05 |
Ester Pro-drugs Of [3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl] Methanol For Lowering Intraocular Pressure
App 20130289088 - Dibas; Mohammed I. ; et al. | 2013-10-31 |
Aryl fluoroethyl ureas acting as alpha 2 adrenergic agents
Grant 8,557,853 - Chow , et al. October 15, 2 | 2013-10-15 |
Method Of Reducing The Severity Of Inflammatory Dermatological Conditions
App 20130217694 - Gil; Daniel W. ; et al. | 2013-08-22 |
Therapeutic Compounds
App 20130217739 - Sinha; Santosh C. ; et al. | 2013-08-22 |
Alpha-2 Adrenergic Agonist Having Long Duration Of Intraocular Pressure-lowering Effect
App 20130210876 - DONELLO; JOHN E. ; et al. | 2013-08-15 |
Pharmaceutical Compositions Comprising 7-(1h-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline For Treating Skin Diseases And Conditions
App 20130203809 - Dibas; Mohammed I. ; et al. | 2013-08-08 |
Ester pro-drugs of [3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl] methanol for lowering intraocular pressure
Grant 8,501,796 - Dibas , et al. August 6, 2 | 2013-08-06 |
Brimonidine For Treating Visual Disorders Mediated By Central Visual Projections From The Eye
App 20130197002 - Staubli; Ursula ; et al. | 2013-08-01 |
Ester pro-drugs of [3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl] methanol
Grant 8,492,557 - Chow , et al. July 23, 2 | 2013-07-23 |
Ester pro-drugs of [3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl] methanol for treating skin diseases and conditions
Grant 8,492,422 - Dibas , et al. July 23, 2 | 2013-07-23 |
Therapeutic compounds
Grant 8,486,969 - Sinha , et al. July 16, 2 | 2013-07-16 |
Method of treating sensorimotor disorders with alpha-2 adrenergic receptor agonists
Grant 8,455,548 - Luhrs , et al. June 4, 2 | 2013-06-04 |
Pharmaceutical Compositions Comprising 7-(1h-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline For Retinal Neuroprotection
App 20130137724 - Dibas; Mohammed I. ; et al. | 2013-05-30 |
Method Of Treating Sensorimotor Disorders With Alpha-2 Adrenergic Receptor Agonists
App 20130137725 - Luhrs; Lauren M.B. ; et al. | 2013-05-30 |
Pharmaceutical Compositions Comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3h-imidazole Derivatives For Treating Retinal Diseases
App 20130131133 - Dibas; Mohammed I. ; et al. | 2013-05-23 |
Pharmaceutical Compositions Comprising 7-(1h-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline For Treating Skin Diseases And Conditions
App 20130123303 - Dibas; Mohammed I. ; et al. | 2013-05-16 |
Topical Dermal Brimonidine Compositions
App 20130102612 - Gil; Daniel W. ; et al. | 2013-04-25 |
Therapeutic compounds
Grant 8,426,454 - Sinha , et al. April 23, 2 | 2013-04-23 |
Pharmaceutical Compositions Comprising 4-bromo-n-(imidazolidin-2-ylidene)-1h-benzimidazol-5-amine For Treating Retinal Diseases
App 20130046003 - Dibas; Mohammed I. ; et al. | 2013-02-21 |
Pharmaceutical Compositions Comprising 4-bromo-n-(imidazolidin-2-ylidene)-1h-benzimidazol-5-amine For Treating Skin Diseases
App 20130023572 - Dibas; Mohammed I. ; et al. | 2013-01-24 |
Alpha-2 Adrenergic Modulators For Treating Visual Disorders Mediated By Central Visual Projections From The Eye
App 20130023573 - Staubli; Ursula V. ; et al. | 2013-01-24 |
Selective alpha 2B/2C agonists
Grant 8,329,918 - Nguyen , et al. December 11, 2 | 2012-12-11 |
Methods of Preventing and Reducing the Severity of Stress-Associated Conditions
App 20120302574 - Gil; Daniel W. ; et al. | 2012-11-29 |
Alpha adrenergic receptor modulators
App 20120238615 - Chow; Ken ; et al. | 2012-09-20 |
Alpha Adrenergic Receptor Modulators
App 20120208821 - Chow; Ken ; et al. | 2012-08-16 |
Unsubstituted And Substituted 4-benzyl-1,3-dihydro-imidazole-2-thiones Acting As Specific Or Selective Alpha2 Adrenergic Agonists And Methods For Using The Same
App 20120196911 - Heidelbaugh; Todd M. ; et al. | 2012-08-02 |
Methods Of Treating Motor Disorders With Alpha-2b Andrenergic Receptor Agonists
App 20120190719 - Gil; Daniel W. ; et al. | 2012-07-26 |
Compositions and methods for treating spasticity
Grant 8,217,059 - Gil , et al. July 10, 2 | 2012-07-10 |
Methods Of Treating Alpha Adrenergic Mediated Conditions
App 20120165380 - Gil; Daniel W. ; et al. | 2012-06-28 |
Ester Pro-drugs Of [3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl] Methanol For Treating Retinal Diseases
App 20120149746 - Dibas; Mohammed I. ; et al. | 2012-06-14 |
Pharmaceutical Compositions Comprising (3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl)methanol
App 20120149747 - Dibas; Mohammad I. ; et al. | 2012-06-14 |
Ester Pro-drugs Of [3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl] Methanol For Lowering Intraocular Pressure
App 20120142746 - Dibas; Mohammed I. ; et al. | 2012-06-07 |
Methods for Treating Diseases of the Retina
App 20120142675 - Kusari; Jyotirmoy ; et al. | 2012-06-07 |
Ester Pro-drugs Of [3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl] Methanol For Treating Skin Diseases And Conditions
App 20120136036 - Dibas; Mohammed I. ; et al. | 2012-05-31 |
4-(1-(3-(hydroxymethyl)-2-methylphenyl)ethyl)-1h-imidazole-2(3h)-thione
App 20120136035 - Gil; Daniel W. | 2012-05-31 |
Ester Pro-drugs Of [3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl] Methanol
App 20120122945 - Chow; Ken ; et al. | 2012-05-17 |
Unsubstituted and substituted 4-benzyl-1,3-dihydro-imidazole-2-thiones acting as specific or selective alpha.sub.2 adrenergic agonists and methods for using the same
Grant 8,178,571 - Heidelbaugh , et al. May 15, 2 | 2012-05-15 |
Alpha-2b Receptor Agonist And Anticonvulsant Compositions For Treating Chronic Pain
App 20120083508 - Gil; Daniel W. ; et al. | 2012-04-05 |
Method Of Activating Regulatory T Cells With Alpha-2b Adrenergic Receptor Agonists
App 20120041031 - Gil; Daniel W. ; et al. | 2012-02-16 |
Methods Of Treating Alpha Adrenergic Mediated Conditions
App 20120035235 - Fang; Wenkui K. ; et al. | 2012-02-09 |
Pyridine Compounds As Subtype Selective Modulators Of Alpha2b And /or Alpha 2c Adrenergic Receptors
App 20110306635 - Nguyen; Phong X. ; et al. | 2011-12-15 |
Pharmaceutical Compositions Comprising (3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl)methanol
App 20110301214 - Gil; Daniel W. | 2011-12-08 |
Methods of treating alpha adrenergic mediated conditions
Grant 8,071,636 - Fang , et al. December 6, 2 | 2011-12-06 |
Imidazole-2-thiones
Grant 8,063,086 - Chow , et al. November 22, 2 | 2011-11-22 |
Method Of Treating Sensorimotor Disorders With 4-(1-(2,3-dimethylphenyl)ethyl)-1h-imidazole-2(3h)-thione
App 20110269805 - Gil; Daniel W. ; et al. | 2011-11-03 |
Compositions And Methods For Treating Spasticity
App 20110212995 - Gil; Daniel W. ; et al. | 2011-09-01 |
Alpha-2 Adrenergic Agonist Having Long Duration Ofintraocular Pressure-lowering Effect
App 20110178145 - Donello; John E. ; et al. | 2011-07-21 |
Therapeutic Compounds
App 20110178143 - Chow; Ken ; et al. | 2011-07-21 |
Therapeutic Compounds
App 20110178144 - Sinha; Santosh C. ; et al. | 2011-07-21 |
Treatment Of Inflammatory Bowel Disease
App 20110172435 - Donde; Yariv ; et al. | 2011-07-14 |
Methods of preventing and reducing the severity of stress-associated conditions
Grant 7,977,335 - Gil , et al. July 12, 2 | 2011-07-12 |
Method Of Treating Motor Disorders With Alpha-2b Adrenergic Receptor Agonists
App 20110160265 - Luhrs; Lauren M.B. ; et al. | 2011-06-30 |
Imidazole-2-thiones
Grant 7,960,423 - Chow , et al. June 14, 2 | 2011-06-14 |
Therapeutic Compounds
App 20110039864 - Sinha; Santosh C. ; et al. | 2011-02-17 |
Nonsedating Alpha-2 Agonists
App 20110034525 - Chow; Ken ; et al. | 2011-02-10 |
Therapeutic fluoroethylcyano guanidines
Grant 7,884,244 - Chow , et al. February 8, 2 | 2011-02-08 |
Substituted Fluoroethyl Ureas As Alpha 2 Adrenergic Agents
App 20110028559 - Fang; Wenkui k. ; et al. | 2011-02-03 |
Selective Alpha 2B/2C Agonists
App 20110028523 - Nguyen; Phong X. ; et al. | 2011-02-03 |
Treatment of inflammatory bowel disease
Grant 7,855,226 - Donde , et al. December 21, 2 | 2010-12-21 |
Unsubstituted And Substituted 4-benzyl-1,3-dihydro-imidazole-2-thiones Acting As Specific Or Selective Alpha2 Adrenergic Agonists And Methods For Using The Same
App 20100298395 - Heidelbaugh; Todd M. ; et al. | 2010-11-25 |
Substituted 2-aminotetralin derivatives as selective alpha 2B agonist
Grant 7,829,587 - Cappiello , et al. November 9, 2 | 2010-11-09 |
Method Of Treating Sensorimotor Disorders With Alpha-2 Adrenergic Receptor Agonists
App 20100240699 - Luhrs; Lauren M.B. ; et al. | 2010-09-23 |
Unsubstituted and substituted 4-benzyl-1,3-dihydro-imidazole-2-thiones acting as specific or selective alpha2 adrenergic agonists and methods for using the same
Grant 7,795,292 - Heidelbaugh , et al. September 14, 2 | 2010-09-14 |
Method Of Treating Motor Disorders With 4-(1-(2,3-dimethylphenyl)ethyl)-1h-imidazole-2(3h)-thione
App 20100216857 - Luhrs; Lauren M.B. ; et al. | 2010-08-26 |
Methods and compositions for modulating alpha adrenergic receptor activity
Grant 7,754,768 - Chow , et al. July 13, 2 | 2010-07-13 |
Therapeutic fluoroethyl ureas
Grant 7,709,507 - Chow , et al. May 4, 2 | 2010-05-04 |
Substituted 3-amino-1-oxo Or Thioxo-1,2,5,6,7,8-hexahydro-2,7-naphthyridine-4-carbonitriles Are Selective Alpha 2b Antagonists
App 20100076194 - CAPPIELLO; John R. ; et al. | 2010-03-25 |
4-(Phenylmethyl and substituted phenylmethyl)-imidazole-2-thiones acting as specific alpha2 adrenergic agonists
Grant 7,683,089 - Heidelbaugh , et al. March 23, 2 | 2010-03-23 |
Alpha-2 Receptor Pan Agonist And Anticonvulsant Compositions For Treating Chronic Pain
App 20100029618 - Gil; Daniel W. ; et al. | 2010-02-04 |
Methods for detecting receptor modulator activity
Grant 7,655,396 - Kedzie , et al. February 2, 2 | 2010-02-02 |
Alpha-2b Adrenergic Receptor Agonist And Serotonin-norepinephrine Reuptake Inhibitor Compositions For Treating Chronic Pain
App 20100016355 - Gil; Daniel W. ; et al. | 2010-01-21 |
Substituted fluoroethyl ureas as alpha 2 adrenergic agents
Grant 7,598,417 - Chow , et al. October 6, 2 | 2009-10-06 |
Selective Subtype Alpha 2 Adrenergic Agents And Methods For Use Thereof
App 20090239918 - Takeuchi; Janet A. ; et al. | 2009-09-24 |
2-((2-thioxo-2,3-dihydro-1H-imidazol-4-yl)methyl)-3,4-dihydronaphthalen-1(- 2H)-one
Grant 7,569,595 - Chow , et al. August 4, 2 | 2009-08-04 |
4-(condensed Cyclicmethyl)-imidazole-2-thiones Acting As Alpha2 Adrenergic Agonists
App 20090176828 - Heidelbaugh; Todd M. ; et al. | 2009-07-09 |
Substituted 2-aminotetralin Derivatives As Selective Alpha 2b Agonist
App 20090176845 - Cappietto; John R. ; et al. | 2009-07-09 |
Therapeutic Fluoroethylcyano Guanidines
App 20080255230 - Chow; Ken ; et al. | 2008-10-16 |
Substituted Fluoroethyl Ureas As Alpha 2 Adrenergic Agents
App 20080255239 - Chow; Ken ; et al. | 2008-10-16 |
4-(heteroaryl-methyl And Substituted Heteroaryl-methyl)-imidazole-2-thiones Acting As Alpha2 Adrenergic Agonists
App 20080221152 - Heidelbaugh; Todd M. ; et al. | 2008-09-11 |
Methods Of Preventing And Reducing The Severity Of Stress-associated Conditions
App 20080207627 - Gil; Daniel W. ; et al. | 2008-08-28 |
Methods Of Preventing And Reducing The Severity Of Stress-associated Conditions
App 20080207628 - Gil; Daniel W. ; et al. | 2008-08-28 |
Aryl Fluoroethyl Ureas Acting As Alpha 2 Adrenergic Agents
App 20080194650 - Chow; Ken ; et al. | 2008-08-14 |
Nonsedating Alpha-2 Agonists
App 20080176918 - Chow; Ken ; et al. | 2008-07-24 |
4-(Heteroaryl-methyl and substituted heteroaryl-methyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists
Grant 7,399,868 - Heidelbaugh , et al. July 15, 2 | 2008-07-15 |
4-(Condensed cyclicmethyl)-imidazole-2-thiones acting as .alpha..sub.2 adrenergic agonists
Grant 7,396,849 - Heidelbaugh , et al. July 8, 2 | 2008-07-08 |
Pan-alpha-2 Receptor Agonist And 5ht4 Serotonin Receptor Compositions For Treating Gastrointestinal Motility Disorders
App 20080153829 - Brooks; Gregory F. ; et al. | 2008-06-26 |
Pan-alpha-2 Receptor Agonist And Acid Reducer Compositions For Treating Gastrointestinal Motility Disorders
App 20080153880 - Brooks; Gregory F. ; et al. | 2008-06-26 |
Alpha-2b Receptor Agonist And Relaxant Compositions For Treating Gastrointestinal Motility Disorders
App 20080153927 - Brooks; Gregory F. ; et al. | 2008-06-26 |
Pan-alpha-2 Receptor Agonist And Relaxant Compositions For Treating Gastrointestinal Motility Disorders
App 20080153832 - Brooks; Gregory F. ; et al. | 2008-06-26 |
Alpha-2b Receptor Agonist And 5ht4 Serotonin Receptor Compositions For Treating Gastrointestinal Motility Disorders
App 20080153825 - Brooks; Gregory F. ; et al. | 2008-06-26 |
Alpha-2b Receptor Agonist And Acid Reducer Compositions For Treating Gastrointestinal Motility Disorders
App 20080153881 - Brooks; Gregory F. ; et al. | 2008-06-26 |
Alpha-2b Receptor Agonist And Anticonvulsant Compositions For Treating Chronic Pain
App 20080153874 - Gil; Daniel W. ; et al. | 2008-06-26 |
Alpha-2 Receptor Pan Agonist And Serotonin-norepinephrine Reuptake Inhibitor Compositions For Treating Chronic Pain
App 20080153808 - Gil; Daniel W. ; et al. | 2008-06-26 |
2-((2-thioxo-2,3-dihydro-1h-imidazol-4-yl)methyl)-3,4-dihydronaphthalen-1(- 2h)-one
App 20080146635 - Chow; Ken ; et al. | 2008-06-19 |
Methods And Compositions For Modulating Alpha Adrenergic Receptor Activity
App 20080132576 - Chow; Ken ; et al. | 2008-06-05 |
Therapeutic and Delivery Methods of Prostaglandin Ep4, Agonists
App 20080132543 - Im; Wha Bin ; et al. | 2008-06-05 |
Imidazole-2-thiones
App 20080097103 - Chow; Ken ; et al. | 2008-04-24 |
Imidazole-2-thiones
App 20080091028 - Chow; Ken ; et al. | 2008-04-17 |
2-((2-Thioxo-2,3-dihydro-1H-imidazol-4-yl)methyl)-3,4-dihydronapthalen-1(2- H)-one
Grant 7,358,269 - Chow , et al. April 15, 2 | 2008-04-15 |
Methods and compositions for alleviating pain
Grant 7,345,065 - Gil , et al. March 18, 2 | 2008-03-18 |
Methods and compositions for modulating alpha adrenergic receptor activity
Grant 7,335,803 - Chow , et al. February 26, 2 | 2008-02-26 |
Treatment of inflammatory bowel disease
Grant 7,326,716 - Old , et al. February 5, 2 | 2008-02-05 |
4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds
Grant 7,323,485 - Chow , et al. January 29, 2 | 2008-01-29 |
Nonsedating .alpha.-2 agonists
Grant 7,312,238 - Chow , et al. December 25, 2 | 2007-12-25 |
Therapeutic Fluoroethyl Ureas
App 20070270498 - Chow; Ken ; et al. | 2007-11-22 |
Use of Memantine and Brimonidine to Attenuate Vitreoretinal Vascular Endothelial Growth Factor (VEGF) Protein Levels in Animals
App 20070203144 - Kusari; Jyotimoy X. ; et al. | 2007-08-30 |
4-(substituted Cycloalkylmethyl) Imidazole-2-thiones, 4-(substituted Cycloalkenylmethyl) Imidazole-2-thiones, 4-(substituted Cycloalkylmethyl) Imidazol-2-ones And 4-(substituted Cycloalkenylmethyl) Imidazol-2-ones And Related Compounds
App 20070072926 - Chow; Ken ; et al. | 2007-03-29 |
Methods for treating pain and hyperhidrosis
App 20070048335 - Gil; Daniel W. ; et al. | 2007-03-01 |
Nonsedating Alpha-2 Agonists
App 20070004790 - Chow; Ken ; et al. | 2007-01-04 |
Methods and compositions for the treatment of diabetes
App 20060293359 - Kusari; Jyotirmoy X. ; et al. | 2006-12-28 |
Nonsedating .alpha.-2 agonists
Grant 7,141,597 - Chow , et al. November 28, 2 | 2006-11-28 |
2-((2-Thioxo-2,3-dihydro-1H-imidazol-4-yl)methyl)-3,4-dihydronaphthalen-1(- 2H)-one
App 20060148872 - Chow; Ken ; et al. | 2006-07-06 |
Unsubstituted and substituted 4-benzyl-1,3-dihydro-imidazole-2-thiones acting as specific or selective alpha2 adrenergic agonists and methods for using the same
App 20060069142 - Heidelbaugh; Todd M. ; et al. | 2006-03-30 |
4-(Condensed cyclicmethyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists
App 20060069144 - Heidelbaugh; Todd M. ; et al. | 2006-03-30 |
4-(Heteroaryl-methyl and substituted heteroaryl-methyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists
App 20060069143 - Heidelbaugh; Todd M. ; et al. | 2006-03-30 |
Treatment of inflammatory bowel disease
App 20050222094 - Burk, Robert M. ; et al. | 2005-10-06 |
Screening methods using a novel human EP prostaglandin receptor
App 20050175605 - Regan, John W. ; et al. | 2005-08-11 |
Treatment of inflammatory bowel disease
App 20050171062 - Old, David W. ; et al. | 2005-08-04 |
Treatment of inflammatory bowel disease
App 20050164992 - Donde, Yariv ; et al. | 2005-07-28 |
Antibodies directed towards a novel human EP prostaglandin receptor
Grant 6,911,531 - Regan , et al. June 28, 2 | 2005-06-28 |
Nonsedating alpha-2 agonists
App 20050059721 - Chow, Ken ; et al. | 2005-03-17 |
Novel methods for identifying improved, non-sedating alpha-2 agonists
App 20050059664 - Gil, Daniel W. ; et al. | 2005-03-17 |
Methods and compositions for the treatment of pain and other alpha 2 adrenergic-mediated conditions
App 20050059744 - Donello, John E. ; et al. | 2005-03-17 |
Methods and compositions for the treatment of pain and other alpha 2 adrenergic-mediated conditions
App 20050058696 - Donello, John E. ; et al. | 2005-03-17 |
Imidiazoles having reduced side effects
Grant 6,841,684 - Chow , et al. January 11, 2 | 2005-01-11 |
Methods of preventing and reducing the severity of stress-associated conditions
App 20040266776 - Gil, Daniel W. ; et al. | 2004-12-30 |
Agent and methods for treating pain
Grant 6,787,517 - Gil , et al. September 7, 2 | 2004-09-07 |
Agents and methods for treating pain
App 20040146532 - Gil, Daniel W. ; et al. | 2004-07-29 |
Methods for the treatment of neurodegeneration
App 20040138312 - Wheeler, Larry A. ; et al. | 2004-07-15 |
Novel methods and compositions for alleviating pain
App 20040132824 - Gil, Daniel W. ; et al. | 2004-07-08 |
Treatment of dementia and parkinson's disease
App 20040116436 - Tatton, William G. ; et al. | 2004-06-17 |
Human EP3 prostaglandin receptor
Grant 6,670,134 - Gil , et al. December 30, 2 | 2003-12-30 |
Novel methods and compositions for alleviating pain
App 20030229088 - Gil, Daniel W. ; et al. | 2003-12-11 |
Methods and compositions for modulating alpha adrenergic receptor activity
App 20030092766 - Chow, Ken ; et al. | 2003-05-15 |
Methods and compositions for modulating alpha adrenergic receptor activity
Grant 6,545,182 - Chow , et al. April 8, 2 | 2003-04-08 |
(2-hydroxy)ethyl-thioureas useful as modulators of .alpha.2B adrenergic receptors
Grant 6,534,542 - Chow , et al. March 18, 2 | 2003-03-18 |
Compounds and method of treatment having agonist-like activity selective at alpha 2B or 2B/2C adrenergic receptors
App 20030023098 - Chow, Ken ; et al. | 2003-01-30 |
(2-hydroxy)ethyl-thioureas useful as modulators of alpha2B adrenergic receptors
App 20020161051 - Chow, Ken ; et al. | 2002-10-31 |
Compounds and method of treatment having agonist-like activity selective at alpha 2B or 2B / 2C adrenergic receptors
App 20020156076 - Chow, Ken ; et al. | 2002-10-24 |
Nucleic acid encoding a novel human EP prostaglandin receptor
App 20020128445 - Regan, John W. ; et al. | 2002-09-12 |
Methods and compositions for modulating alpha adrenergic receptor activity
App 20020058839 - Chow, Ken ; et al. | 2002-05-16 |
Methods of treating pain and other conditions
Grant 6,329,369 - Chow , et al. December 11, 2 | 2001-12-11 |
Method for treating ocular pain
App 20010031754 - Gil, Daniel W. ; et al. | 2001-10-18 |
Method for treating ocular pain
Grant 6,294,553 - Gil , et al. September 25, 2 | 2001-09-25 |
| 